Glasheen James Walter

Director at Revance Therapeutics, Inc. · on record since Feb 11, 2014
Director at SOLENO THERAPEUTICS INC · on record since Mar 10, 2017
10% owner at SOLENO THERAPEUTICS INC · on record since Apr 13, 2017

Insider trading activity of Glasheen James Walter

Transactions on record: 27; since Feb 11, 2014

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing Jun 18, 2018

Figures computed from official regulatory filings — methodology.

Companies where Glasheen James Walter has traded

SOLENO THERAPEUTICS INC7 tx · $22.2K · Jun 18, 2018
Revance Therapeutics, Inc.20 tx · May 9, 2016

Track record of Glasheen James Walter

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Glasheen James Walter

Co-insiders of Glasheen James Walter

Abingworth Bioventures VII LPSOLENO THERAPEUTICS INC
Abingworth LLPSOLENO THERAPEUTICS INC
ALEXANDER W JAMESSOLENO THERAPEUTICS INC
Allouche CyrilRevance Therapeutics, Inc.
Anish BhatnagarSOLENO THERAPEUTICS INC
BDF IV Annex Fund LPSOLENO THERAPEUTICS INC
Beraud JillRevance Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
SOLENO THERAPEUTICS INC	Jun 18, 2018	AwardD	15,931	0.00 USD	$0	SEC
SOLENO THERAPEUTICS INC	Feb 7, 2018	Award	3,962	1.73 USD	$6.9K	SEC
SOLENO THERAPEUTICS INC	Oct 4, 2017	Award	13,154	0.52 USD	$6.8K	SEC
SOLENO THERAPEUTICS INC	Jul 17, 2017	Award	11,213	0.61 USD	$6.8K	SEC
SOLENO THERAPEUTICS INC	May 9, 2017	AwardD	45,139	0.00 USD	$0	SEC
SOLENO THERAPEUTICS INC	Apr 13, 2017	Award	2,578	0.63 USD	$1.6K	SEC
SOLENO THERAPEUTICS INC	Mar 10, 2017	AwardD	20,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 9, 2016	AwardD	8,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 14, 2015	AwardD	8,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	Apr 10, 2014	AwardD	8,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-303,563	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-2,801	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	52,087	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-81,959	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-34,427	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-4,546	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	34,427	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-74,665	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-89,186	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	622,648	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	149	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-52,087	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-4,125	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-5,231	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-149	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
SOLENO THERAPEUTICS INC	Jun 18, 2018	AwardD	15,931	0.00 USD	$0	SEC
SOLENO THERAPEUTICS INC	Feb 7, 2018	Award	3,962	1.73 USD	$6.9K	SEC
SOLENO THERAPEUTICS INC	Oct 4, 2017	Award	13,154	0.52 USD	$6.8K	SEC
SOLENO THERAPEUTICS INC	Jul 17, 2017	Award	11,213	0.61 USD	$6.8K	SEC
SOLENO THERAPEUTICS INC	May 9, 2017	AwardD	45,139	0.00 USD	$0	SEC
SOLENO THERAPEUTICS INC	Apr 13, 2017	Award	2,578	0.63 USD	$1.6K	SEC
SOLENO THERAPEUTICS INC	Mar 10, 2017	AwardD	20,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 9, 2016	AwardD	8,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 14, 2015	AwardD	8,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	Apr 10, 2014	AwardD	8,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-303,563	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-2,801	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	52,087	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-81,959	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-34,427	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-4,546	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	34,427	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-74,665	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-89,186	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	622,648	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	149	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-52,087	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-4,125	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-5,231	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD	-149	—	—	SEC